Rituximab and 131iodine-tositumomab produce similar survival for follicular ... ModernMedicine NEW YORK (Reuters Health) - Added to standard CHOP chemotherapy, both rituximab and radioimmunotherapy (RIT) produce excellent results in patients presenting with advanced follicular lymphoma, a Southwest Oncology Group study shows. "My view of ... |
